IRIDEX Past Earnings Performance
Past criteria checks 0/6
IRIDEX's earnings have been declining at an average annual rate of -2.3%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 7% per year.
Key information
-2.3%
Earnings growth rate
3.1%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 7.0% |
Return on equity | -255.7% |
Net Margin | -21.8% |
Last Earnings Update | 29 Jun 2024 |
Recent past performance updates
Recent updates
Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive
Jun 11Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?
May 14Iridex's Strategic Review Process Should Bear Fruit 'Soon'
Mar 28Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues
Feb 14Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Oct 04Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop
Aug 12Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Apr 14We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely
Oct 12Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?
Feb 25Iridex To Benefit From New Revolutionary Glaucoma Treatment
Jan 11Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long
Jan 03IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines
Dec 23Revenue & Expenses Breakdown
How IRIDEX makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
29 Jun 24 | 50 | -11 | 25 | 6 |
30 Mar 24 | 50 | -11 | 25 | 7 |
30 Dec 23 | 52 | -10 | 25 | 7 |
30 Sep 23 | 55 | -8 | 25 | 7 |
01 Jul 23 | 56 | -8 | 26 | 7 |
01 Apr 23 | 57 | -7 | 26 | 7 |
31 Dec 22 | 57 | -8 | 26 | 7 |
01 Oct 22 | 57 | -9 | 25 | 8 |
02 Jul 22 | 56 | -9 | 25 | 8 |
02 Apr 22 | 55 | -6 | 24 | 8 |
01 Jan 22 | 54 | -5 | 23 | 7 |
02 Oct 21 | 51 | -3 | 22 | 6 |
03 Jul 21 | 46 | -3 | 21 | 5 |
03 Apr 21 | 39 | -7 | 20 | 4 |
02 Jan 21 | 36 | -6 | 19 | 3 |
26 Sep 20 | 36 | -8 | 20 | 3 |
27 Jun 20 | 38 | -8 | 20 | 3 |
28 Mar 20 | 42 | -7 | 22 | 3 |
28 Dec 19 | 43 | -9 | 23 | 4 |
28 Sep 19 | 43 | -10 | 24 | 4 |
29 Jun 19 | 44 | -11 | 26 | 4 |
30 Mar 19 | 44 | -12 | 26 | 4 |
29 Dec 18 | 43 | -13 | 26 | 4 |
29 Sep 18 | 41 | -15 | 26 | 4 |
30 Jun 18 | 41 | -15 | 26 | 5 |
31 Mar 18 | 41 | -15 | 25 | 5 |
30 Dec 17 | 42 | -13 | 23 | 5 |
30 Sep 17 | 44 | -19 | 22 | 5 |
01 Jul 17 | 43 | -16 | 20 | 5 |
01 Apr 17 | 45 | -14 | 19 | 5 |
31 Dec 16 | 46 | -12 | 18 | 5 |
01 Oct 16 | 46 | 0 | 17 | 5 |
02 Jul 16 | 46 | 1 | 16 | 5 |
02 Apr 16 | 43 | 0 | 15 | 5 |
02 Jan 16 | 42 | 0 | 14 | 5 |
03 Oct 15 | 41 | 9 | 15 | 5 |
04 Jul 15 | 42 | 9 | 15 | 5 |
04 Apr 15 | 43 | 10 | 15 | 5 |
03 Jan 15 | 43 | 10 | 14 | 5 |
27 Sep 14 | 42 | 2 | 14 | 4 |
28 Jun 14 | 41 | 2 | 14 | 4 |
29 Mar 14 | 40 | 2 | 13 | 4 |
28 Dec 13 | 38 | 2 | 13 | 4 |
Quality Earnings: IRIX is currently unprofitable.
Growing Profit Margin: IRIX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRIX is unprofitable, and losses have increased over the past 5 years at a rate of 2.3% per year.
Accelerating Growth: Unable to compare IRIX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IRIX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Return on Equity
High ROE: IRIX has a negative Return on Equity (-255.7%), as it is currently unprofitable.